Safia Costes

12.1k total citations
32 papers, 1.7k citations indexed

About

Safia Costes is a scholar working on Surgery, Cell Biology and Molecular Biology. According to data from OpenAlex, Safia Costes has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 13 papers in Cell Biology and 11 papers in Molecular Biology. Recurrent topics in Safia Costes's work include Pancreatic function and diabetes (26 papers), Endoplasmic Reticulum Stress and Disease (13 papers) and Diabetes Treatment and Management (6 papers). Safia Costes is often cited by papers focused on Pancreatic function and diabetes (26 papers), Endoplasmic Reticulum Stress and Disease (13 papers) and Diabetes Treatment and Management (6 papers). Safia Costes collaborates with scholars based in France, United States and Canada. Safia Costes's co-authors include Peter C. Butler, Tatyana Gurlo, Stéphane Dalle, Jacqueline F. Rivera, Christophe Broca, Aleksey V. Matveyenko, Gyslaine Bertrand, Marie Daval, Christine Longuet and D. Bataille and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Cell Biology.

In The Last Decade

Safia Costes

32 papers receiving 1.7k citations

Peers

Safia Costes
Connie A. Marshall United States
James Cantley United Kingdom
David A. Jacobson United States
Malin Fex Sweden
Francesca Frigerio Switzerland
Connie A. Marshall United States
Safia Costes
Citations per year, relative to Safia Costes Safia Costes (= 1×) peers Connie A. Marshall

Countries citing papers authored by Safia Costes

Since Specialization
Citations

This map shows the geographic impact of Safia Costes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Safia Costes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Safia Costes more than expected).

Fields of papers citing papers by Safia Costes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Safia Costes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Safia Costes. The network helps show where Safia Costes may publish in the future.

Co-authorship network of co-authors of Safia Costes

This figure shows the co-authorship network connecting the top 25 collaborators of Safia Costes. A scholar is included among the top collaborators of Safia Costes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Safia Costes. Safia Costes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varrault, Annie, Julia Sabatier, Christophe Broca, et al.. (2023). GLP-1 and GIP receptors signal through distinct β-arrestin 2-dependent pathways to regulate pancreatic β cell function. Cell Reports. 42(11). 113326–113326. 44 indexed citations
2.
Brown, Matthew, Christophe Broca, Gyslaine Bertrand, et al.. (2022). The nuclear receptor REV-ERBα is implicated in the alteration of β-cell autophagy and survival under diabetogenic conditions. Cell Death and Disease. 13(4). 353–353. 12 indexed citations
4.
Costes, Safia. (2018). Targeting protein misfolding to protect pancreatic beta-cells in type 2 diabetes. Current Opinion in Pharmacology. 43. 104–110. 23 indexed citations
5.
Gurlo, Tatyana, Magalie A. Ravier, Anne Wojtusciszyn, et al.. (2018). Proteasomal degradation of the histone acetyl transferase p300 contributes to beta-cell injury in a diabetes environment. Cell Death and Disease. 9(6). 600–600. 15 indexed citations
6.
Costes, Safia, Dany Muller, Annie Varrault, et al.. (2017). ERK1 is dispensable for mouse pancreatic beta cell function but is necessary for glucose-induced full activation of MSK1 and CREB. Diabetologia. 60(10). 1999–2010. 16 indexed citations
7.
Costes, Safia, Tatyana Gurlo, Jacqueline F. Rivera, & Peter C. Butler. (2014). UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in β-cells. Autophagy. 10(6). 1004–1014. 58 indexed citations
8.
Costes, Safia, Ralf Langen, Tatyana Gurlo, Aleksey V. Matveyenko, & Peter C. Butler. (2013). β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?. Diabetes. 62(2). 327–335. 98 indexed citations
9.
Dalle, Stéphane, Julie Quoyer, Elodie M. Varin, & Safia Costes. (2011). Roles and Regulation of the Transcription Factor CREB in Pancreatic β -Cells. Current Molecular Pharmacology. 4(3). 187–195. 63 indexed citations
10.
Daval, Marie, Tatyana Gurlo, Safia Costes, Changjiang Huang, & Peter C. Butler. (2011). Cyclin-Dependent Kinase 5 Promotes Pancreatic β-Cell Survival via Fak-Akt Signaling Pathways. Diabetes. 60(4). 1186–1197. 37 indexed citations
11.
Rivera, Jacqueline F., Tatyana Gurlo, Marie Daval, et al.. (2010). Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic β-cells: protective role of p62-positive cytoplasmic inclusions. Cell Death and Differentiation. 18(3). 415–426. 115 indexed citations
12.
Huang, Changjiang, Tatyana Gurlo, Leena Haataja, et al.. (2009). Calcium-activated Calpain-2 Is a Mediator of Beta Cell Dysfunction and Apoptosis in Type 2 Diabetes. Journal of Biological Chemistry. 285(1). 339–348. 82 indexed citations
13.
Quoyer, Julie, Christine Longuet, Christophe Broca, et al.. (2009). GLP-1 Mediates Antiapoptotic Effect by Phosphorylating Bad through a β-Arrestin 1-mediated ERK1/2 Activation in Pancreatic β-Cells. Journal of Biological Chemistry. 285(3). 1989–2002. 155 indexed citations
14.
Annicotte, Jean‐Sébastien, Émilie Blanchet, Carine Chavey, et al.. (2009). The CDK4–pRB–E2F1 pathway controls insulin secretion. Nature Cell Biology. 11(8). 1017–1023. 100 indexed citations
15.
Broca, Christophe, Julie Quoyer, Safia Costes, et al.. (2008). β-Arrestin 1 Is Required for PAC1 Receptor-mediated Potentiation of Long-lasting ERK1/2 Activation by Glucose in Pancreatic β-Cells. Journal of Biological Chemistry. 284(7). 4332–4342. 32 indexed citations
16.
Costes, Safia, et al.. (2006). Tolérance et efficacité d’une entretoise articulée dans les reprises en deux temps de prothèses de genou infectées. Revue de Chirurgie Orthopédique et Réparatrice de l Appareil Moteur. 92(5). 485–489. 4 indexed citations
17.
Bataille, D., Ghislaine Fontès, Safia Costes, Christine Longuet, & Stéphane Dalle. (2006). The Glucagon–Miniglucagon Interplay. Annals of the New York Academy of Sciences. 1070(1). 161–166. 11 indexed citations
18.
Longuet, Christine, Christophe Broca, Safia Costes, et al.. (2004). Extracellularly Regulated Kinases 1/2 (p44/42 Mitogen-Activated Protein Kinases) Phosphorylate Synapsin I and Regulate Insulin Secretion in the MIN6 β-Cell Line and Islets of Langerhans. Endocrinology. 146(2). 643–654. 93 indexed citations
19.
Costes, Safia, Christine Longuet, Christophe Broca, et al.. (2004). Cooperative Effects between Protein Kinase A and p44/p42 Mitogen‐Activated Protein Kinase to Promote cAMP‐Responsive Element Binding Protein Activation after β Cell Stimulation by Glucose and Its Alteration Due to Glucotoxicity. Annals of the New York Academy of Sciences. 1030(1). 230–242. 20 indexed citations
20.
Costes, Safia, et al.. (1996). [Gardnerella vaginalis in a newborn infant: contamination or infection, apropos of a case].. PubMed. 54(8-9). 333–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026